Biomarkers in Swiss Multiple Sclerosis Cohort (SMSC) and large studies

    • Determinants of Brain Atrophy in Multiple Sclerosis

    • Treatment effects of Brain Atrophy and Lesion changes in Multiple Sclerosis

    • Brain Repair in Multiple Sclerosis: location and clinical correlates

    • Diagnostic value of CVS and cortical lesions for MS diagnosis (MAGNIMS)

    • Spinal cord Atrophy as prognostic tool in Multiple Sclerosis

This page is under construction.

  • PD Dr Katrin Parmar
  • Dr Athina Papadopoulou
  • PD Dr Regina Schläger
  • PD Dr Özgür Yaldizli
  • Prof Dr Cristina Granziera